Tumor suppressor protein DAB2IP participates in chromosomal stability maintenance through activating spindle assembly checkpoint and stabilizing kinetochore-microtubule attachments
Resource
Nucleic Acids Res., 44(18), 8842-8854
Journal
Nucleic Acids Research
Pages
8842-8854
Date Issued
2016
Date
2016
Author(s)
Yu, Lan
Shang, Zeng-Fu
Abdisalaam, Salim
Lee, Kyung-Jong
Gupta, Arun
Hsieh, Jer-Tsong
Asaithamby, Aroumougame
Chen, Benjamin P. C.
Saha, Debabrata
Abstract
Defects in kinetochore-microtubule (KT-MT) attachment and the spindle assembly checkpoint (SAC) during cell division are strongly associated with chromosomal instability (CIN). CIN has been linked to carcinogenesis, metastasis, poor prognosis and resistance to cancer therapy. We previously reported that the DAB2IP is a tumor suppressor, and that loss of DAB2IP is often detected in advanced prostate cancer (PCa) and is indicative of poor prognosis. Here, we report that the loss of DAB2IP results in impaired KT-MT attachment, compromised SAC and aberrant chromosomal segregation. We discovered that DAB2IP directly interacts with Plk1 and its loss inhibits Plk1 kinase activity, thereby impairing Plk1-mediated BubR1 phosphorylation. Loss of DAB2IP decreases the localization of BubR1 at the kinetochore during mitosis progression. In addition, the reconstitution of DAB2IP enhances the sensitivity of PCa cells to microtubule stabilizing drugs (paclitaxel, docetaxel) and Plk1 inhibitor (BI2536). Our findings demonstrate a novel function of DAB2IP in the maintenance of KT-MT structure and SAC regulation during mitosis which is essential for chromosomal stability.
SDGs
Other Subjects
4 (8 cyclopentyl 7 ethyl 5,6,7,8 tetrahydro 5 methyl 6 oxo 2 pteridinylamino) 3 methoxy n (1 methyl 4 piperidinyl)benzamide; Bub1 related protein; docetaxel; paclitaxel; polo like kinase 1; protein DAB2IP; tumor suppressor protein; unclassified drug; cell cycle protein; DAB2IP protein, human; guanosine triphosphatase activating protein; oncoprotein; polo-like kinase 1; protein binding; protein serine threonine kinase; tubulin modulator; aneuploidy; Article; cancer resistance; cell adhesion; chemosensitivity; chromosomal instability; chromosome segregation; controlled study; enzyme activation; enzyme activity; HCT116 cell line; human; human cell; kinetochore microtubule; M phase cell cycle checkpoint; mitosis inhibition; priority journal; prostate cancer cell line; protein depletion; protein function; protein localization; protein phosphorylation; protein protein interaction; sensitivity analysis; animal; antagonists and inhibitors; cell cycle checkpoint; chromosome aberration; drug effects; gene inactivation; genetics; kinetochore; metabolism; microtubule; mitosis; mouse; phosphorylation; protein transport; RNA interference; spindle apparatus; tumor cell line; Animals; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Line, Tumor; Chromosomal Instability; Chromosome Aberrations; Chromosome Segregation; Gene Knockout Techniques; Humans; Kinetochores; Mice; Microtubules; Mitosis; Phosphorylation; Protein Binding; Protein Transport; Protein-Serine-Threonine Kinases; Proto-Oncogene Proteins; ras GTPase-Activating Proteins; RNA Interference; Spindle Apparatus; Tubulin Modulators